1. Home
  2. TXG vs GAB Comparison

TXG vs GAB Comparison

Compare TXG & GAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$20.54

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Gabelli Equity Trust Inc. (The)

GAB

Gabelli Equity Trust Inc. (The)

HOLD

Current Price

$6.15

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TXG
GAB
Founded
2012
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Investment Managers
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
TXG
GAB
Price
$20.54
$6.15
Analyst Decision
Hold
Analyst Count
14
0
Target Price
$15.61
N/A
AVG Volume (30 Days)
2.3M
667.8K
Earning Date
02-11-2026
01-01-0001
Dividend Yield
N/A
10.91%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$641,814,000.00
N/A
Revenue This Year
$4.50
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.92
N/A
52 Week Low
$6.78
$4.56
52 Week High
$21.50
$5.88

Technical Indicators

Market Signals
Indicator
TXG
GAB
Relative Strength Index (RSI) 64.64 49.19
Support Level $20.01 $6.08
Resistance Level $21.50 $6.22
Average True Range (ATR) 1.16 0.06
MACD 0.30 -0.00
Stochastic Oscillator 83.15 43.75

Price Performance

Historical Comparison
TXG
GAB

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About GAB Gabelli Equity Trust Inc. (The)

Gabelli Equity Trust Inc is a non-diversified closed-end management investment company. Its primary investment objective is the long-term growth of capital with income as a secondary objective. The Fund invests at least its assets in equity securities under normal market conditions. Its equity portfolio includes common stock, preferred stock, convertible or exchangeable securities, and warrants and rights to purchase such securities selected by the Investment Adviser. The company invests in various sectors, of which Food & Beverage, Financial Services, Equipment and Supplies, Entertainment, Consumer Products, Health Care, Diversified Industrial, Business Services, Consumer Services and others.

Share on Social Networks: